Bruce C. Cozadd

CIK: 0001193210

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)37 (68.5%)

Position reduction

Option Exercises (M)2 (3.7%)

Derivative conversions

Awards (A)5 (9.3%)

Compensation grants

Other (G, F, J, C, D, …)10 (18.5%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (2)

JAZZ

Jazz Pharmaceuticals plc

Director

SLRN

ACELYRIN, Inc.

Director

Discretionary Trading P&L

Holdings

Transaction History (54 total)

JAZZ
Jazz Pharmaceuticals plc
Oct 1, 2026
Sale(S)
Direct
6K shares at avg. $230.33$1.4M
JAZZ
Jazz Pharmaceuticals plc
Sep 1, 2026
Sale(S)
Direct
6K shares at avg. $250.13$1.5M
JAZZ
Jazz Pharmaceuticals plc
Aug 31, 2026
Tax Payment(F)
Direct
1.2K shares at avg. $241.39$292K
JAZZ
Jazz Pharmaceuticals plc
Aug 31, 2026
Tax Payment(F)
Direct
10 shares at avg. $244.06$2K
JAZZ
Jazz Pharmaceuticals plc
Aug 5, 2026
Award(A)
Direct
1.6K shares-
JAZZ
Jazz Pharmaceuticals plc
Aug 3, 2026
Sale(S)
Direct
6K shares at avg. $252.98$1.5M
JAZZ
Jazz Pharmaceuticals plc
Jul 1, 2026
Sale(S)
Direct
6K shares at avg. $240.47$1.4M
JAZZ
Jazz Pharmaceuticals plc
Jun 1, 2026
Sale(S)
Direct
6K shares at avg. $235.12$1.4M
JAZZ
Jazz Pharmaceuticals plc
May 1, 2026
Sale(S)
Direct
6K shares at avg. $203.33$1.2M
JAZZ
Jazz Pharmaceuticals plc
Apr 1, 2026
Sale(S)
Direct
3.7K shares at avg. $190.22$701K
JAZZ
Jazz Pharmaceuticals plc
Apr 1, 2026
Sale(S)
Direct
2.3K shares at avg. $190.94$438K
JAZZ
Jazz Pharmaceuticals plc
Apr 1, 2026
Sale(S)
Direct
24 shares at avg. $191.74$5K
JAZZ
Jazz Pharmaceuticals plc
Mar 5, 2026
Tax Payment(F)
Direct
15.1K shares at avg. $188.69$2.9M
JAZZ
Jazz Pharmaceuticals plc
Mar 3, 2026
Sale(S)
Direct
2.6K shares at avg. $186.73$487K
JAZZ
Jazz Pharmaceuticals plc
Mar 3, 2026
Sale(S)
Direct
233 shares at avg. $187.84$44K
JAZZ
Jazz Pharmaceuticals plc
Mar 3, 2026
Sale(S)
Direct
3.2K shares at avg. $186.09$588K
JAZZ
Jazz Pharmaceuticals plc
Jan 16, 2026
Award(A)
Direct
35.9K shares-
JAZZ
Jazz Pharmaceuticals plc
Jan 16, 2026
Tax Payment(F)
Direct
17.5K shares at avg. $171.16$3.0M
JAZZ
Jazz Pharmaceuticals plc
Nov 26, 2025
Exercise(M)
Direct
811 shares at avg. $123.36$100K
JAZZ
Jazz Pharmaceuticals plc
Nov 26, 2025
Exercise(M)
Direct
76.7K shares at avg. $123.36$9.5M
JAZZ
Jazz Pharmaceuticals plc
Nov 26, 2025
Sale(S)
Direct
38.1K shares at avg. $177.27$6.8M
JAZZ
Jazz Pharmaceuticals plc
Nov 26, 2025
Sale(S)
Direct
507 shares at avg. $179.79$91K
JAZZ
Jazz Pharmaceuticals plc
Nov 26, 2025
Sale(S)
Direct
8.4K shares at avg. $179.23$1.5M
JAZZ
Jazz Pharmaceuticals plc
Nov 26, 2025
Sale(S)
Direct
30.5K shares at avg. $178.06$5.4M
JAZZ
Jazz Pharmaceuticals plc
Nov 20, 2025
Award(A)
Direct
2.5K shares-

		Type	Shares	Price		Ownership
Oct 1, 2026	JAZZ Jazz Pharmaceuticals plc	Sale(S)	6,000	$230.33	$1,381,980	Direct
Sep 1, 2026	JAZZ Jazz Pharmaceuticals plc	Sale(S)	6,000	$250.13	$1,500,780	Direct
Aug 31, 2026	JAZZ Jazz Pharmaceuticals plc	Tax Payment(F)	1,209	$241.39	$291,840	Direct
Aug 31, 2026	JAZZ Jazz Pharmaceuticals plc	Tax Payment(F)	10	$244.06	$2,441	Direct
Aug 5, 2026	JAZZ Jazz Pharmaceuticals plc	Award(A)	1,605	-	$0	Direct
Aug 3, 2026	JAZZ Jazz Pharmaceuticals plc	Sale(S)	6,000	$252.98	$1,517,880	Direct
Jul 1, 2026	JAZZ Jazz Pharmaceuticals plc	Sale(S)	6,000	$240.47	$1,442,820	Direct
Jun 1, 2026	JAZZ Jazz Pharmaceuticals plc	Sale(S)	6,000	$235.12	$1,410,720	Direct
May 1, 2026	JAZZ Jazz Pharmaceuticals plc	Sale(S)	6,000	$203.33	$1,219,980	Direct
Apr 1, 2026	JAZZ Jazz Pharmaceuticals plc	Sale(S)	3,684	$190.22	$700,778	Direct
Apr 1, 2026	JAZZ Jazz Pharmaceuticals plc	Sale(S)	2,292	$190.94	$437,631	Direct
Apr 1, 2026	JAZZ Jazz Pharmaceuticals plc	Sale(S)	24	$191.74	$4,602	Direct
Mar 5, 2026	JAZZ Jazz Pharmaceuticals plc	Tax Payment(F)	15,114	$188.69	$2,851,861	Direct
Mar 3, 2026	JAZZ Jazz Pharmaceuticals plc	Sale(S)	2,608	$186.73	$487,002	Direct
Mar 3, 2026	JAZZ Jazz Pharmaceuticals plc	Sale(S)	233	$187.84	$43,768	Direct
Mar 3, 2026	JAZZ Jazz Pharmaceuticals plc	Sale(S)	3,159	$186.09	$587,843	Direct
Jan 16, 2026	JAZZ Jazz Pharmaceuticals plc	Award(A)	35,917	-	$0	Direct
Jan 16, 2026	JAZZ Jazz Pharmaceuticals plc	Tax Payment(F)	17,453	$171.16	$2,987,255	Direct
Nov 26, 2025	JAZZ Jazz Pharmaceuticals plc	Exercise(M)	811	$123.36	$100,045	Direct
Nov 26, 2025	JAZZ Jazz Pharmaceuticals plc	Exercise(M)	76,689	$123.36	$9,460,355	Direct
Nov 26, 2025	JAZZ Jazz Pharmaceuticals plc	Sale(S)	38,126	$177.27	$6,758,672	Direct
Nov 26, 2025	JAZZ Jazz Pharmaceuticals plc	Sale(S)	507	$179.79	$91,155	Direct
Nov 26, 2025	JAZZ Jazz Pharmaceuticals plc	Sale(S)	8,380	$179.23	$1,501,943	Direct
Nov 26, 2025	JAZZ Jazz Pharmaceuticals plc	Sale(S)	30,487	$178.06	$5,428,567	Direct
Nov 20, 2025	JAZZ Jazz Pharmaceuticals plc	Award(A)	2,506	-	-	Direct

1-25 of 54 transactions

About COZADD BRUCE C

COZADD BRUCE C (SEC CIK 0001193210) files insider reports with the SEC as Director of Jazz Pharmaceuticals plc (JAZZ) and Director of ACELYRIN, Inc. (SLRN).

Signal8 holds 29 ownership filings by COZADD BRUCE C, all Form 4s, filed between Nov 5, 2024 and Oct 5, 2026. Those filings report 54 transactions, from Nov 1, 2024 to Oct 1, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on COZADD BRUCE C's filings is in DUBLIN 4.

Recent filings by COZADD BRUCE C

Oct 1, 2026: Open-market sale of JAZZ shares (Form 4, code S).
Sep 1, 2026: Open-market sale of JAZZ shares (Form 4, code S).
Aug 31, 2026: Tax withholdings of JAZZ shares (2 lines, Form 4, code F).
Aug 5, 2026: Grant or award of JAZZ shares (Form 4, code A).
Aug 3, 2026: Open-market sale of JAZZ shares (Form 4, code S).

Other insiders filing for Jazz Pharmaceuticals plc (JAZZ)

GALA RENEE D, President & CEO
Patil Neena M, EVP & Chief Legal Officer
Henderson Mary Elizabeth, SVP, Technical Operations
Smith Mark Douglas, Director
RIEDEL NORBERT G, Director
LOVE TED W, Director

How to read Form 4 transaction codes